Targeted radionuclide therapy: an evolution toward precision cancer treatment

H Jadvar - American Journal of Roentgenology, 2017 - Am Roentgen Ray Soc
OBJECTIVE. This article reviews recent developments in targeted radionuclide therapy
(TRT) approaches directed to malignant liver lesions, bone metastases, neuroendocrine …

The role of interventional radiology for the treatment of hepatic metastases from neuroendocrine tumor: an updated review

M Barat, AS Cottereau, A Kedra, S Dermine… - Journal of clinical …, 2020 - mdpi.com
Interventional radiology plays an important role in the management of patients with
neuroendocrine tumor liver metastasis (NELM). Transarterial embolization (TAE) …

Intrahepatic cholangiocarcinoma treated with transarterial yttrium-90 glass microsphere radioembolization: results of a single institution retrospective study

A Gangi, J Shah, N Hatfield, J Smith, J Sweeney… - Journal of Vascular and …, 2018 - Elsevier
Purpose To evaluate the efficacy and safety of transarterial yttrium-90 glass microsphere
radioembolization in patients with unresectable intrahepatic cholangiocarcinoma (ICC) …

[HTML][HTML] A comprehensive machine learning benchmark study for radiomics-based survival analysis of CT imaging data in patients with hepatic metastases of CRC

AT Stüber, S Coors, B Schachtner, T Weber… - Investigative …, 2023 - journals.lww.com
Objectives Optimizing a machine learning (ML) pipeline for radiomics analysis involves
numerous choices in data set composition, preprocessing, and model selection. Objective …

Yttrium-90 radioembolization for hepatocellular carcinoma: Outcome prediction with MRI derived fat-free muscle area

A Faron, AM Sprinkart, CC Pieper, DLR Kuetting… - European journal of …, 2020 - Elsevier
Purpose Sarcopenia is associated with adverse outcomes in several gastrointestinal
malignancies and liver cirrhosis. We aimed to study the utility of magnetic resonance …

A pooled analysis of transarterial radioembolization with yttrium-90 microspheres for the treatment of unresectable intrahepatic cholangiocarcinoma

Y Zhen, B Liu, Z Chang, H Ren, Z Liu… - OncoTargets and …, 2019 - Taylor & Francis
Purpose The aim of this pooled analysis was to evaluate the clinical efficacy and safety of
transarterial radioembolization (TARE) with yttrium-90 (90Y) microspheres for the treatment …

Neuroendocrine liver metastases treated using transarterial radioembolization: identification of prognostic parameters at 68Ga-DOTATATE PET/CT

M Ingenerf, F Grawe, M Winkelmann, H Karim… - Diagnostic and …, 2024 - Elsevier
Purpose To identify prognostic clinical and imaging parameters for patients with
neuroendocrine liver metastases (NELMs) undergoing transarterial radioembolization …

Prediction of 90Y radioembolization outcome from pretherapeutic factors with random survival forests

M Ingrisch, F Schöppe, K Paprottka… - Journal of Nuclear …, 2018 - Soc Nuclear Med
Our objective was to predict the outcome of 90Y radioembolization in patients with
intrahepatic tumors from pretherapeutic baseline parameters and to identify predictive …

Liver embolisation for patients with neuroendocrine neoplasms: systematic review

R Kanabar, J Barriuso, MG McNamara… - …, 2021 - karger.com
Background: Liver embolisation is one of the treatment options available for patients
diagnosed with neuro-endocrine neoplasms (NEN). It is still uncertain whether the benefits …

Selective internal radiation therapy of metastatic breast cancer to the liver: A meta-analysis

C Liu, G Tadros, Q Smith, L Martinez, J Jeffries… - Frontiers in …, 2022 - frontiersin.org
Introduction The aim of this study is to conduct a meta-analysis to assess the efficacy of
yttrium-90 selective internal radiation therapy (SIRT) in treating patients with breast cancer …